Skip to main content
. 2015 Dec 23;17(1):9. doi: 10.3390/ijms17010009

Table 1.

Information of different transcription factors (TFs) in uni- and bi-directional promoters.

TATA-Less or TATA-Containing Promoters TF Name Location Sequence (5′–3′) Bidirectional Promoter Unidirectional Promoter Mechanism
TATA-box lacking promoters INR −3–+5 YYANWYY 25.30% [7,59] 30.80% [7,59] It can function independently, and together with the TATA box or DPE [7,44,45,59].
BRE −37–−32 SSRCGCC 16.50% [7,59] 11.10% [7,59] TFIIB–BRE interaction may play a dominant role in the assembly of the pre-initiation complex and transcription initiation [7,58,59].
CCAAT −75–−80 GGCCAATCT 12.9% [7,59] 6.90% [7,59] Enhances the transcriptional rate [7].
DPE +28–+32 DSWYVY(T) 46.65% [7,59] 50.60% [7,59] It can be recognized by TBP-associated factors (TAFs), such as TAF6 and TAF9 [58,59].
TATA-box containing promoters Sp1 Ubiquitously located near the TSS [66] GGGGCGG / / Sp1 acts through its zinc finger domain at the carboxyl end to interact with GC rich sequences of downstream target genes [56,57,67]. It binds to the GC-rich box and recruits TFIID to regulate the bidirectional promoter HIV-1 LTR [66,68]. Recognizes the core sequence 5-GGGGCGGG-3 of the target promoter.
NF-κB / / / / It binds to the DNA sequence: 5-GGGRNYYY-3 [68,69,70].
TATA −25–−30 TATAAA 9% [59] 29% [59] TATA box and INR interact synergistically when they are separated by 25–30 bp [7,44,59,64].
CpGI 5′-regions of housekeeping genes and many tissues-specific genes [66] size: 0.5–2 kb in length 77% [7,71], enriched binding sites of many transcription factors: Sp1, GABPA, MYC, E2F1, E2F4, Nrf1, YY1, NF-Y [42,72,73]; 86.37% [72]. 56% [43]; 38%, compared with a bidirectional promoter, more lack GC-pairs [7,71]; 28.48% [72]. Hypermethylation of a CpGI in the promoter region usually suppresses gene expression [74,75,76], and the promoters of some tumor suppressor genes are hypermethylated in cancer [7,71,77]. Bi-directional genes tend to relate to housekeeping functions in metabolism pathways and nuclear processes [66,72].

Information derived from Orekhova and Rubtsov (2013) [7], Lepoivre et al. (2013) [42], Hildebrandt et al. (1992) [43], Silverman et al. (1992) [44], Duart-Garcia and Braunschweig (2014) [45], Gazon et al. (2012) [56], Yoshida et al. (2008) [57], Xie et al. (2007) [58], Yang and Elnitski (2008) [59], Abe and Gemmell (2014) [64], Wierstra (2008) [66], Zanotto et al. (2008) [67], Arpin-André et al. (2014) [68], Bentley et al. (2004) [69], Kobayashi-Ishihara et al. (2012) [70], Tufarelli et al. (2013) [71], Liu et al. (2011) [72], Lin et al. (2007) [73], Li et al. (2011) [74], Weber et al. (2010) [75], Rao et al. (2013) [76] and Shu et al. (2006) [77]. (DNA fragment no less than 500 bp with a GC-content ≥55% and Obs/Exp value ≥0.60). R, N, and Y denote for any purine, any pyrimidine, and any nucleotide, respectively.